arrow
Back
M

Marina Chiara Garassino

University of Chicago

73H-index
916Paper Count
4.4WCitation Count
Published Papers 176
Publication Date
Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models
err2026-08-04
err0
errOAAI
errFederica Corso; Aleksandra Zec; Margherita Favali; Marta Ligero; Lars Hilgers; Luca Mauro Invernizzi; Laura Mazzeo; Adria Marcos Morales; Gustav Anton Müller-Franzes; Ines Prata Machado; Felix Busch; Vanja Mišković; Francesco Trovò; Claudia Proto; Giuseppe Lo Russo; Mario Occhipinti; Marta Brambilla; Teresa Beninato; Susan Halabi; Marina Chiara Garassino
errShare
errSave
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC
err2026-04-08
err0
PREAI
errMarina Chiara Garassino; Sophie Cousin; Benjamin Besse; Adrian Sacher; Sergey Orlov; Michael Schenker; Enriqueta Felip; Oleg Gladkov; Cristina H. Messina; Antara Majumdar; Zhenhua Jeremy Wu; Natalie O. Karpinich; Steven Hirschfeld; Marc Ballas; Martin Reck
errShare
errSave
Network analysis predicts pembrolizumab response in advanced NSCLC with PD-L1 < 50%
err2026-03-26
err0
errOAAI
errMario Occhipinti; Antonella Cruoglio; Silvia Marchesi; Arsela Prelaj; Marco Petrilli; Aurelia Rughetti; Paolo Ambrosini; Elisabetta Ferretti; Claudia Proto; Monica Ganzinelli; Marta Brambilla; Laura Mazzeo; Teresa Beninato; Filippo de Braud; Marina Chiara Garassino; Lorenzo Farina; Giuseppe Lo Russo; Manuela Petti
errShare
errSave
Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes
err2026-02-04
err0
errOAAI
errUri Zvi; Shivam Mundhra; David Ovetsky; Qing Chen; Aidan R. Jones; Stella Wang; Maria J. Román-Vazquez; Marie Kim; Udoka M. Ibeh; Michele Ferro; Kunle Odunsi; Marina C. Garassino; Michael E. Flatté; Melody A. Swartz; Denis R. Candido; Aaron Esser-Kahn; Peter C. Maurer
errShare
errSave
Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital Pathology
err2025-12-11
err0
PREAI
errMatteo Sacco; Erica Pietroluongo; Anna Di Lello; Mirella Marino; Alexander McGeough; Alessandra Esposito; Rishi Sharma; Aliya N. Husain; Qudsia Arif; Maha A.T. Elsebaie; Alexander T. Pearson; James M. Dolezal; Marina Chiara Garassino
errShare
errSave
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Sara Stumpo; Francesco Mantuano; Andrea De Giglio; Francesca Lo Bianco; Federica Pecci; Joao V Alessi; Xinan Wang; Francesca Sperandi; Barbara Melotti; Francesco Gelsomino; Ferdinandos Skoulidis; Marina C Garassino; Solange Peters; Mark M Awad; Andrea Ardizzoni; Biagio Ricciuti
errShare
errSave
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
errShare
errSave
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study
err2025-08-05
err0
errOAAI
errNiels Reinmuth; Jonathan W. Goldman; Yuanbin Chen; Katsuyuki Hotta; Dmytro Trukhin; Galina Statsenko; Maximilian Hochmair; Mustafa Özgüroğlu; Jun Ho Ji; Marina Chiara Garassino; Artem Poltoratskiy; Francesco Verderame; Libor Havel; Igor Bondarenko; György Losonczy; Nikolay Conev; Shannon Kummer; Helen Mann; Priti Chugh; Tapashi Dalvi; Luis Paz-Ares
errShare
errSave
THE ITALIAN MAURIS PHASE IIIB TRIAL OF ATEZOLIZUMAB PLUS CARBOPLATIN AND ETOPOSIDE FOR PATIENTS WITH NEWLY DIAGNOSED EXTENSIVE-STAGE SMALL CELL LUNG CANCER: 3-YEAR END-OF-STUDY RESULTS
err2025-07-09
err0
errOAAI
errFloriana Morgillo; Ester Del Signore; Emilio Bria; Filippo de Marinis; Fortunato Ciardiello; Marina Chiara Garassino; Alessio Stefani; Francesco Verderame; Alessandro Morabito; Andrea Sbrana; Giuseppe Tonini; Marina Gilli; Rossana Berardi; Paola Adriana Taveggia; Alessandra Bearz; Angelo Delmonte; Maria Rita Migliorino; Cesare Gridelli; Giovanni Maria Fadda; Manuela Iero; Andrea Ardizzoni
errShare
errSave
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer
err2025-06-11
err0
errOAAI
errMarina C. Garassino; Ying Cheng; Delvys Rodriguez-Abreu; Silvia Novello; Julien Mazieres; Andrew G. Robinson; Steven F. Powell; Balazs Halmos; Jhanelle E. Gray; Meihua Wang; Cong Chen; Jing Yang; Fabricio Souza; Paul Schwarzenberger; Luis Paz-Ares
errShare
errSave
Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer—final analysis from the phase II PACIFIC-6 trial
err2025-06-01
err0
errOAAI
errM.C. Garassino; J. Khalifa; M. Reck; C. Chouaid; H. Bischoff; N. Reinmuth; L. Cove-Smith; T. Mansy; D.L. Cortinovis; M.R. Migliorino; A. Delmonte; J. Garcia Sánchez; L.E. Chara Velarde; R. Bernabe; L. Paz-Ares; P. Chander; I. Diaz Perez; K. Foroutanpour; U. Emeribe; C. Faivre-Finn
errShare
errSave
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis
err2025-06-01
err1
PREAI
errNuccio, Antonio; Salomone, Fabio; Servetto, Alberto; Ricciuti, Biagio; Marinelli, Daniele; Bulotta, Alessandra; Veronesi, Giulia; Garassino, Marina Chiara; Torri, Valter; Besse, Benjamin; Viscardi, Giuseppe; Ferrara, Roberto
errShare
errSave
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study
err2025-05-07
err0
errOAAI
errOzguroglu, Mustafa; Goldman, Jonathan W.; Chen, Yuanbin; Garassino, Marina Chiara; Medic, Nenad; Mann, Helen; Chugh, Priti; Dalvi, Tapashi; Paz-Ares, Luis
errShare
errSave
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1
err2025-03-19
err0
errOAAI
errSaadettin Kilickap; Ana Baramidze; Ahmet Sezer; Mustafa Özgüroğlu; Mahmut Gumus; Igor Bondarenko; Miranda Gogishvili; Marina Nechaeva; Michael Schenker; Irfan Cicin; Ho Gwo Fuang; Yaroslav Kulyaba; Kasimova Zyuhal; Roxana-Ioana Scheusan; Marina Chiara Garassino; Yuntong Li; Cong Zhu; Manika Kaul; Javier Perez; Frank Seebach; Heather Magnan
errShare
errSave
Non-small-cell lung cancer (vol 10, 71, 2024)
err2025-01-07
err0
PREAI
errHendriks, Lizza E. L.; Remon, Jordi; Faivre-Finn, Corinne; Garassino, Marina C.; Heymach, John V.; Kerr, Keith M.; Tan, Daniel S. W.; Veronesi, Giulia
errShare
errSave
Non-small-cell lung cancer
err2024-09-26
err0
PREAI
errHendriks, Lizza E. L.; Remon, Jordi; Faivre-Finn, Corinne; Garassino, Marina C.; Heymach, John V.; Kerr, Keith M.; Tan, Daniel S. W.; Veronesi, Giulia; Reck, Martin
errShare
errSave
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errSpicer, Jonathan D.; Garassino, Marina C.; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gaston L.; Bylicki, Olivier; Rodriguez-Abreu, Delvys; Chaft, Jamie E.; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M.; Samkari, Ayman; Gao, Shugeng
errShare
errSave
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
err2024-06-01
err0
errOAAI
errOu, Sai-Hong Ignatius; Le, Xiuning; Nagasaka, Misako; Reungwetwattana, Thanyanan; Ahn, Myung-Ju; Lim, Darren W. T.; Santos, Edgardo S.; Shum, Elaine; Lau, Sally C. M.; Lee, Jii Bum; Calles, Antonio; Wu, Fengying; Lopes, Gilberto; Sriuranpong, Virote; Tanioki, Junko; Horinouchi, Hidehito; Garassino, Marina C.; Popat, Sanjay; Besse, Benjamin; Rosell, Rafael; Soo, Ross A.
errShare
errSave
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
err2024-05-30
err4
errOAAI
errXie, Mingchao; Vuko, Miljenka; Rodriguez-Canales, Jaime; Zimmermann, Johannes; Schick, Markus; O'Brien, Cathy; Paz-Ares, Luis; Goldman, Jonathan W.; Garassino, Marina Chiara; Gay, Carl M.; Heymach, John V.; Jiang, Haiyi; Barrett, J. Carl; Stewart, Ross A.; Lai, Zhongwu; Byers, Lauren A.; Rudin, Charles M.; Shrestha, Yashaswi
errShare
errSave
Pathologic endpoints as surrogates for survival endpoints in neoadjuvant immunotherapy clinical trials for non-small cell lung cancer
err2024-03-22
err0
PREAI
errCameron, Robert B.; Hines, Jacobi B.; Esposito, Alessandra; Bestvina, Christine; Garassino, Marina C.; Torri, Valter; Thawani, Rajat
errShare
errSave